Skip to main content
Innovotech Inc. logo

Innovotech Inc. — Investor Relations & Filings

Ticker · IOT ISIN · CA45772U1049 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 330 across all filing types
Latest filing 2021-08-13 AGM Information
Country CA Canada
Listing TSXV IOT

About Innovotech Inc.

https://innovotech.ca/

Innovotech Inc. is a specialist in antimicrobial and biofilm solutions, recognized as a pioneer in biofilm product development and contract research. The company focuses on providing innovative and practical solutions to medical, agricultural, and industrial problems caused by microbial biofilms. Key offerings include specialized assay kits used globally for growing microbial biofilms in research applications. Through Innovotech Labs, the company provides comprehensive, accredited (GMP and ISO) contract testing services, including analytical, microbiological, and antimicrobial testing. These services target the pharmaceutical, biotechnology, medical device, and nutraceutical industries, aiming to ensure regulatory compliance and product optimization.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a letter from Computershare to Canadian Securities Regulatory Authorities regarding an upcoming Annual General and Special Meeting of Innovotech Inc. It provides details such as meeting type, record dates, meeting date, location, and proxy material handling. The content is an announcement about the meeting logistics and voting security details, not the meeting materials or results themselves. The document length is short (1038 characters) and it does not contain any financial data or detailed reports. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or related announcements about the meeting.
2021-08-13 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification statement by the CFO regarding the interim financial report and interim MD&A for the period ended March 31, 2021. It explicitly states it is a certification of interim filings, not the filings themselves. The document length is short (1108 characters), and it contains no actual financial data or analysis, only attestation. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR).
2021-05-26 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO regarding the interim financial report and interim MD&A for the period ended March 31, 2021. It explicitly states it is a certification of interim filings, not the filings themselves. The document length is short (1212 characters), and it contains no actual financial data or analysis, only a statement of review and fairness. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR).
2021-05-26 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three-month Period Ended March 31, 2021.' It contains detailed financial data and analysis for the quarter ending March 31, 2021, including revenues, net income, assets, liabilities, and shareholder equity. It also discusses business strategy, outlook, and subsequent events. The presence of substantive financial data and management's discussion for a quarterly period indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2021
2021-05-26 English
Interim financial statements/report – English.pdf
Regulatory Filings Classification · 100% confidence The document is a certification letter from the CEO confirming that the Notice of Meeting and Management Proxy Circular for the 2021 annual meeting have been sent to relevant parties. It does not contain financial data or the actual proxy circular, but rather attests to the distribution of these materials. The document length is short (745 characters), and it serves as an officer certification. According to the rules, such certifications should be classified as Regulatory Filings (RNS).
2021-05-26 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Financial Statements (Unaudited) For the three-month period ended March 31, 2021 and 2020' and contains detailed financial statements including Statements of Financial Position, Statements of Operations and Comprehensive Income (Loss), Statements of Cash Flows, and Notes to Financial Statements. It explicitly states it is unaudited interim financial statements for a quarter (three-month period). The document length is over 10,000 characters, indicating it is a full report rather than a brief announcement. The presence of substantive financial data and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. Therefore, the correct classification is IR (Interim / Quarterly Report). Q1 2021
2021-05-26 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.